Niraparib for the Treatment of Metastatic NSCLC in a Patient With BRCA2 Germinal Mutation: A Case Report

Clin Lung Cancer. 2024 Mar;25(2):175-179. doi: 10.1016/j.cllc.2023.10.012. Epub 2023 Oct 29.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • BRCA2 Protein / genetics
  • Humans
  • Indazoles / therapeutic use
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mutation / genetics
  • Piperidines / therapeutic use

Substances

  • niraparib
  • Indazoles
  • Piperidines
  • BRCA2 protein, human
  • BRCA2 Protein